Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy

Psychiatry and Behavioural Sciences, Stanford University, Palo Alto, CA 94304-5742, USA
The Journal of Physiology (Impact Factor: 4.54). 07/2007; 581(Pt 2):649-63. DOI: 10.1113/jphysiol.2007.129510
Source: PubMed

ABSTRACT Recent population studies have identified important interrelationships between sleep duration and body weight regulation. The hypothalamic hypocretin/orexin neuropeptide system is able to influence each of these. Disruption of the hypocretin system, such as occurs in narcolepsy, leads to a disruption of sleep and is often associated with increased body mass index. We examined the potential interrelationship between the hypocretin system, metabolism and sleep by measuring locomotion, feeding, drinking, body temperature, sleep/wake and energy metabolism in a mouse model of narcolepsy (ataxin-ablation of hypocretin-expressing neurons). We found that locomotion, feeding, drinking and energy expenditure were significantly reduced in the narcoleptic mice. These mice also exhibited severe sleep/wake fragmentation. Upon awakening, transgenic and control mice displayed a similar rate of increase in locomotion and food/water intake with time. A lack of long wake episodes partially or entirely explains observed differences in overall locomotion, feeding and drinking in these transgenic mice. Like other parameters, energy expenditure also rose and fell depending on the sleep/wake status. Unlike other parameters, however, energy expenditure in control mice increased upon awakening at a greater rate than in the narcoleptic mice. We conclude that the profound sleep/wake fragmentation is a leading cause of the reduced locomotion, feeding, drinking and energy expenditure in the narcoleptic mice under unperturbed conditions. We also identify an intrinsic role of the hypocretin system in energy expenditure that may not be dependent on sleep/wake regulation, locomotion, or food intake. This investigation illustrates the need for coordinated study of multiple phenotypes in mouse models with altered sleep/wake patterns.

Download full-text


Available from: Jamie Zeitzer, Aug 17, 2015
1 Follower
  • Source
    • ". The F group had increased levels of blood glucose during the 2 h sampling ( +43 – 47% , P < 0 . 01 compared with QC and MC ) . F , sleep - fragmented group ; MC , motor control group ; QC quiet control group . this point , SF displayed by a murine model of narcolepsy is thought to be responsible for the metabolic changes observed in these mice ( Zhang et al . , 2007 ) . Altogether , these and our data indicate that SF represents an allostatic load on endocrine and autonomous systems that might , in the long term , lead to the development of diseases ."
    [Show abstract] [Hide abstract]
    ABSTRACT: Sleep fragmentation is present in numerous sleep pathologies and constitutes a major feature of patients with obstructive sleep apnea. A prevalence of metabolic syndrome, diabetes and obesity has been shown to be associated to obstructive sleep apnea. While sleep fragmentation has been shown to impact sleep homeostasis, its specific effects on metabolic variables are only beginning to emerge. In this context, it is important to develop realistic animal models that would account for chronic metabolic effects of sleep fragmentation. We developed a 14-day model of instrumental sleep fragmentation in mice, and show an impact on both brain-specific and general metabolism. We first report that sleep fragmentation increases food intake without affecting body weight. This imbalance was accompanied by the inability to adequately decrease brain temperature during fragmented sleep. In addition, we report that sleep-fragmented mice develop glucose intolerance. We also observe that sleep fragmentation slightly increases the circadian peak level of glucocorticoids, a factor that may be involved in the observed metabolic effects. Our results confirm that poor-quality sleep with sustained sleep fragmentation has similar effects on general metabolism as actual sleep loss. Altogether, these results strongly suggest that sleep fragmentation is an aggravating factor for the development of metabolic dysfunctions that may be relevant for sleep disorders such as obstructive sleep apnea.
    Journal of Sleep Research 06/2012; 22(1). DOI:10.1111/j.1365-2869.2012.01029.x · 2.95 Impact Factor
  • Source
    • "Obesity is a multi-factorial condition in humans and characteristics of obesity are common in animal models. Some models show deficient leptin or orexin signaling similar to obese individuals and narcoleptic patients (Beck et al., 2001; Laposky et al., 2006; Megirian et al., 1998; Sanchez-Alavez et al., 2007; Tschop and Heiman, 2001; Zhang et al., 2007), but unlike human obesity, obesity in several models results from a single gene deficiency. Sleep architecture in these animal models resemble the abnormalities observed in human obesity (excessive sleep, specifically during the active phase; sleep fragmentation; decreased REM sleep during the resting phase). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The rapid rise in obesity prevalence in the modern world parallels a significant reduction in restorative sleep (Agras et al., 2004; Dixon et al., 2007, 2001; Gangwisch and Heymsfield, 2004; Gupta et al., 2002; Sekine et al., 2002; Vioque et al., 2000; Wolk et al., 2003). Reduced sleep time and quality increases the risk for obesity, but the underlying mechanisms remain unclear (Gangwisch et al., 2005; Hicks et al., 1986; Imaki et al., 2002; Jennings et al., 2007; Moreno et al., 2006). A majority of the theories linking human sleep disturbances and obesity rely on self-reported sleep. However, studies with objective measurements of sleep/wake parameters suggest a U-shaped relationship between sleep and obesity. Studies in animal models are needed to improve our understanding of the association between sleep disturbances and obesity. Genetic and experimenter-induced models mimicking characteristics of human obesity are now available and these animal models will be useful in understanding whether sleep disturbances determine propensity for obesity, or result from obesity. These models exhibit weight gain profiles consistently different from control animals. Thus a careful evaluation of animal models will provide insight into the relationship between sleep disturbances and obesity in humans. In this review we first briefly consider the fundamentals of sleep and key sleep disturbances, such as sleep fragmentation and excessive daytime sleepiness (EDS), observed in obese individuals. Then we consider sleep deprivation studies and the role of circadian alterations in obesity. We describe sleep/wake changes in various rodent models of obesity and obesity resistance. Finally, we discuss possible mechanisms linking sleep disturbances with obesity.
    Neuroscience & Biobehavioral Reviews 03/2012; 36(3):1015-29. DOI:10.1016/j.neubiorev.2012.01.001 · 10.28 Impact Factor
  • Source
    • "orexin neurons are ablated at 4 months of age. They showed that orexin KO mice have elevated body temperature during sleep (Mochizuki et al., 2006) and that orexin neuron-ablated mice have an attenuated body temperature fluctuation (Zhang et al., 2007). Recently, they investigated the implication of orexin in stress-induced hyperthermia and found that orexin KO mice show normal temperature changes in response to handling stress, while orexin neuron-ablated mice showed the expected attenuation of stressinduced hyperthermia (Zhang et al., 2010). "
    [Show abstract] [Hide abstract]
    ABSTRACT: In this chapter, we give an overview of the current status of the role of orexins in feeding and energy homeostasis. Orexins, also known as hypocretins, initially were discovered in 1998 as hypothalamic regulators of food intake. A little later, their far more important function as regulators of sleep and arousal came to light. Despite their restricted distribution, orexin neurons have projections throughout the entire brain, with dense projections especially to the paraventricular nucleus of the thalamus, the arcuate nucleus of the hypothalamus, and the locus coeruleus and tuberomammillary nucleus. Its two receptors are orexin receptor 1 and orexin receptor 2. These receptors show a specific and localized distribution in a number of brain regions, and a variety of different actions has been demonstrated upon their binding. Our group showed that through the autonomic nervous system, the orexin system plays a key role in the control of glucose metabolism, but it has also been shown to stimulate sympathetic outflow, to increase body temperature, heart rate, blood pressure, and renal sympathetic nerve activity. The well-known effects of orexin on the control of food intake, arousal, and wakefulness appear to be more extensive than originally thought, with additional effects on the autonomic nervous system, that is, to increase body temperature and energy metabolism.
    Progress in brain research 01/2012; 198:47-64. DOI:10.1016/B978-0-444-59489-1.00005-7 · 5.10 Impact Factor
Show more